Robert B. Carter, Quest Diagnostics other

Director, SEC Form 4, filed on October 23, 2026
10 sharesNot an open-market purchase or sale
Transaction date
October 21, 2026
Shares held after
Could not be calculated
Change in holding
Could not be calculatedFrom the transactions in the filing
Filing rows
1None is a purchase or sale

Price context

DGX daily close, Apr 27 to October 26, 2026
$247.45$186.61
Daily close
Grants, options, tax
Transaction price
Not reportedNot an open-market trade
Close on trade date
$238.93October 21, 2026
Latest close
$242.92October 26, 2026
Since the trade
+1.67%vs the close on trade date

Transactions in the filing

DateTransactionSecuritySharesPriceAmountAfter
Other
Common stockDirect
10
$235.93
$2,359
3,874

Recent filings at Quest Diagnostics

Full history
PersonTransactionAmount or sharesDate
Sam SamadCFO
Grant
+90 shares
Vicky B. GreggDirector
Grant
+63 shares
J. E. DavisCEO
Sale
$2.43 million
Michael E. PrevoznikChief legal officer
SaleOption exercise
$5.51 million
Mark E. DelaneyChief commercial officer
Sale
$376,288
Sam SamadCFO
Grant
+102 shares
Vicky B. GreggDirector
Grant
+72 shares